发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| Turkey | 210 |
| USA | 176 |
| CHINA MAINLAND | 73 |
| Italy | 50 |
| Japan | 38 |
| GERMANY (FED REP GER) | 37 |
| France | 29 |
| Canada | 28 |
| Saudi Arabia | 28 |
| England | 26 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| ISTANBUL UNIVERSITY | 40 |
| UNIVERSITY OF TEXAS SYSTEM | 26 |
| HACETTEPE UNIVERSITY | 22 |
| DISKAPI YILDIRIM BEYAZIT TRAINING & RES... | 18 |
| ASSISTANCE PUBLIQUE HOPITAUX PARIS (APH... | 17 |
| CHINESE ACADEMY OF MEDICAL SCIENCES - P... | 15 |
| HARVARD UNIVERSITY | 15 |
| UNIVERSITY OF HEALTH SCIENCES TURKEY | 15 |
| UNIVERSITY OF ROCHESTER | 15 |
| STATE UNIVERSITY SYSTEM OF FLORIDA | 14 |
文章引用情况
1
Is there an epidemic of chronic lymphocytic leukaemia (CLL) in China?2
Genomic aberrations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events3
Identification of a novel, internal tRNA-derived RNA fragment as a new prognostic and screening biomarker in chronic lymphocytic leukemia, using an innovative quantitative real-time PCR assay4
Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent doses5
Pharmacogenomics and variations in the risk of toxicity during the consolidation/maintenance phases of the treatment of pediatric B-cell leukemia patients from an admixed population in the Brazilian Amazon6
Inhibition of NAMPT sensitizes MOLT4 leukemia cells for etoposide treatment through the SIRT2-p53 pathway7
Monitoring of clonal evolution of double C-KIT exon 17 mutations by Droplet Digital PCR in patients with core-binding factor acute myeloid leukemia8
Incorporating newer agents in the treatment of acute myeloid leukemia9
Next-generation antigen receptor sequencing of paired diagnosis and relapse samples of B-cell acute lymphoblastic leukemia: Clonal evolution and implications for minimal residual disease target selection10
Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma